Reader Comments
Post a new comment on this article
Post Your Discussion Comment
Please follow our guidelines for comments and review our competing interests policy. Comments that do not conform to our guidelines will be promptly removed and the user account disabled. The following must be avoided:
- Remarks that could be interpreted as allegations of misconduct
- Unsupported assertions or statements
- Inflammatory or insulting language
Thank You!
Thank you for taking the time to flag this posting; we review flagged postings on a regular basis.
closeAbsence of structures
Posted by cdsouthan on 23 Dec 2012 at 12:13 GMT
Considering the profile of this journal with respect to transparency, the omission of the explicit inhibitor chemical structures is unexpected. Without them the key experiments in the paper cannot be reproduced
RE: Absence of structures
eportan replied to cdsouthan on 04 Feb 2013 at 11:46 GMT
Novartis is willing to provide the inhibitor they supplied for this study under a Material Transfer Agreement for academic research and non-commercial purposes. Please contact Ulf Neumann (ulf.neumann@novartis.com).
Compound S is identical to compound J in the published BACE2/diabetes Cell metabolism paper:
Cell Metabolism, Volume 14, issue 3, 7 september 2011, Pages 365-377. This reference describes the synthesis in more detail:
2-Aminodihydro[1,3]thiazines as BACE 2 inhibitors and their preparation and use in the treatment of diabetes.
Beauchamp, Jeremy; Benardeau, Agnes; Hilpert, Hans; Migliorini, Cristiano; Riboulet, William; Wang, Haiyan
PCT Int. Appl. (2011), WO 2011029803 A1’